M Ventures
Amsterdamm-ventures.com
Overview
M Ventures is the strategic, corporate venture capital fund of Merck KGaA, Darmstadt, Germany, that invests globally in the fields of biotechnology and technology, including healthcare, life sciences, electronics, and sustainability.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cyllene Therapeutics | Jul 2026 | Series C | Lead |
| Cyllene Therapeutics | Jul 2026 | Series C | Lead |
| TRIMTECH Therapeutics | Jun 2026 | Seed | Co-investor |
| Future Fertility | Apr 2026 | Series A Extension | Lead |
| STORM Therapeutics | Apr 2026 | Series C | Co-investor |
Key People
Björn Kuhl
Member Of The Board Of Directors
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
